市場調査レポート
商品コード
1468169
心臓ペースメーカーの市場:タイプ、技術、適応症、エンドユーザー、地域別、2024年~2032年Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
心臓ペースメーカーの市場:タイプ、技術、適応症、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
世界の心臓ペースメーカー市場規模は2023年に50億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて3.5%の成長率(CAGR)を示し、2032年までに68億米ドルに達すると予測しています。CVDの有病率の増加、健康保険加入者の増加、手術技術向上のための広範な研究開発(R&D)が市場を牽引する主な要因です。
心臓ペースメーカーは、電気パルスを使用して心臓のリズム障害を治療するために胸部または腹部に植え込まれる小型の医療機器であり、心拍の調節と監視を補助します。マイクロプロセッサー、センサー、電極、ワイヤー、リード線、ハウジングなどの電子部品や機械部品があり、患者の要求に応じてカスタマイズすることができます。心拍数が不規則になったり遅くなったりすることによって引き起こされる脳卒中や心不全などの合併症のリスクを軽減するのに役立ちます。このほか、心臓ペースメーカーは植え込み型除細動器や心臓再同期療法機器に組み込まれ、より包括的な治療アプローチを提供します。現在、主要プレーヤーは、患者が耐えやすく、外科医が植え込みやすいように、小型で侵襲性の低い心臓ペースメーカーを導入しています。
大衆の間で心血管疾患(CVDs)の有病率が急上昇していることは、世界中で心臓ペースメーカーの需要を促進している主な要因の一つです。さらに、不整脈、先天性心疾患、心房細動などの病気にかかりやすい高齢化人口の増加が市場の成長を後押ししています。加えて、健康意識の高まりと、心臓に関連する病気に対する利用可能な代替治療法についての認識が、市場にプラスの影響を与えています。これとは別に、心臓ペースメーカーに経済的支援を提供し、医療費を削減する健康保険に加入する人の増加が市場成長に寄与しています。さらに、主要企業は、より長い電池寿命と、ヘルスケア専門家がスマートフォンを使用して遠隔でデバイスの性能と患者の心機能を追跡できる遠隔監視機能を備えた心臓ペースメーカーを発売しています。主要企業はまた、ペースメーカー移植に伴う感染やその他の合併症のリスクを最小限に抑えるため、心臓ペースメーカーの製造に生体適合性材料を使用することに注力しています。これに加えて、心臓ペースメーカーにワイヤレス技術を統合し、デバイスとの間でデータを伝送することで、デバイスの精度と信頼性を向上させることができ、市場の成長を促進しています。さらに、各国の行政機関は、手術技術を向上させ、ヘルスケア施設へのアクセスを容易にするために、研究開発(R&D)活動に投資しています。
The global cardiac pacemaker market size reached US$ 5.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The increasing prevalence of CVDs, rising number of people with health insurance policies, and extensive research and development (R&D) activities for improving surgical techniques represent some of the key factors driving the market.
A cardiac pacemaker is a small medical device implanted in the chest or abdomen to treat heart rhythm disorders using electrical pulses, which assist in regulating and monitoring the heartbeat. It has electronic and mechanical components, such as microprocessors, sensors, electrodes, wires, leads, and housing, and can be customized according to the requirements of the patient. It helps reduce the risk of complications like stroke and heart failure that can be caused by an irregular or slow heart rate. Besides this, a cardiac pacemaker is incorporated into implantable defibrillators and cardiac resynchronization therapy devices to offer a more comprehensive treatment approach. At present, key players are introducing small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant.
The surging prevalence of cardiovascular diseases (CVDs) among the masses represents one of the major factors driving the demand for cardiac pacemakers around the world. Moreover, the rising aging population, which is more prone to ailments, such as arrhythmias, congenital heart disease, and atrial fibrillation, is favoring the market growth. In addition, the growing health consciousness and awareness about the available treatment alternatives for heart-related ailments are influencing the market positively. Apart from this, the increasing number of people with health insurance policies that provide financial assistance for cardiac pacemakers and reduce medical expenses is contributing to the market growth. Furthermore, leading players are launching cardiac pacemakers with longer battery life and remote monitoring capabilities that allow healthcare professionals to track the performance of the device and heart function of patients remotely using a smartphone. Key players are also focusing on using biocompatible materials in the manufacturing of cardiac pacemakers to minimize the risk of infection and other complications associated with pacemaker implantation. Besides this, the integration of wireless technology in cardiac pacemakers to transmit data to and from the device that can help improve the accuracy and reliability of the device is propelling the growth of the market. Additionally, governing agencies of numerous countries are investing in research and development (R&D) activities to improve surgical techniques and provide easy access to healthcare facilities.
IMARC Group provides an analysis of the key trends in each segment of the global cardiac pacemaker market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, technology, indication, and end user.
Implantable
External
The report has provided a detailed breakup and analysis of the cardiac pacemaker market based on the type. This includes implantable and external. According to the report, implantable represented the largest segment.
Biventricular
Single Chambered
Dual Chambered
Others
A detailed breakup and analysis of the cardiac pacemaker market based on the technology has also been provided in the report. This includes biventricular, single chambered, dual chambered, and others. According to the report, dual chambered accounted for the largest market share.
Arrhythmias
Congestive Heart Failure
Others
The report has provided a detailed breakup and analysis of the cardiac pacemaker market based on the indication. This includes arrhythmias, congestive heart failure, and others. According to the report, arrhythmias represented the largest segment.
Hospitals and Clinics
Ambulatory Surgery Centers
Others
A detailed breakup and analysis of the cardiac pacemaker market based on the end user has also been provided in the report. This includes hospitals and clinics, ambulatory surgery centers, and others. According to the report, hospitals and clinics accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for cardiac pacemaker. Some of the factors driving the North America cardiac pacemaker market included the growing incidences of cardiac disorders, rising geriatric population, the launch of MRI-compatible pacemakers and Bluetooth-enabled pacemakers, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac pacemaker market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.